Peter Colman

Test–retest reliability of evoked BOLD signals from a cognitive–emotive fMRI test battery

Michael M. Plichta, Adam J. Schwarz, O. Grimm et al. · NeuroImage · 2012 · 311 citations · Full text

Life Sciences, Neuroscience, Behavioral Neuroscience +14

Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles

Chris Chamberlain, Peter Colman, Ann Ranger et al. · Annals of the Rheumatic Diseases · 2017 · 105 citations

Life Sciences, Immunology, Pharmacology +17

The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)

Mark Fidock, B E Souberbielle, Carl Laxton et al. · Clinical Pharmacology & Therapeutics · 2011 · 70 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Statistical Issues in First-In-Man Studies

Stephen Senn, Dipti Amin, Sheila M. Bird et al. · Journal of the Royal Statistical Society Series A (Statistics in Society) · 2007 · 68 citations

Medicine, Biostatistics, Pharmacology +12

Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis

Márcia Cristina Teixeira dos Santos, D. Scheller, Claudia Schulte et al. · PLoS ONE · 2018 · 45 citations · Full text

Life Sciences, Neurology, Neuroscience +17